Analyzing...
Loading company...
Neogen Chemicals Ltd. engages in the manufacture of specialty chemicals which are used in pharmaceutical, engineering, and agro chemical industries. The company employs 493 full-time employees The company went IPO on 2019-05-08. The Company’s products include organic chemicals, advance intermediates, inorganic chemicals, chemistries and grignard reagents. The firm operates through three segments: organic chemicals, inorganic chemicals, and custom synthesis and manufacturing. Organic chemicals segment is involved in the manufacturing of organic bromine-based compounds, advanced intermediates, specialty compounds and Grignard reagents. The inorganic chemicals segment is involved in manufacturing inorganic lithium and bromine salts. Custom synthesis and manufacturing segment is involved in developing and manufacturing new processes and customized products.
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹862 Cr revenue.
COGS 54.1%, employees 10.5%.
“anticipate mechanical completion before end of this year, commence trial production followed by commercial production in Q1 FY27 (April 2026)”
“We are very confident that '27, there will be a very strong demand, and we should see a demand improvement in h1 FY twenty seven. But FY twenty six did not pan out the way we had envisioned”
“Next year, when we hit full utilization $9.50 to 1,000 crore on standalone basis, we expect the same 18% plus or minus 1.5% kind of margin.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 3.5%▼ | 7.7% |
| ROCE | 6.8%▼ | 10.8% |
| Net Margin | 3.3%▼ | 5.1% |
| EBITDA Margin | 16.6%▲ | 11.1% |
| Debt To Equity | 1.63x▲ | 0.18x |
| Rev Growth 3yr | 7.9%▲ | 2.0% |
| EPS Growth 3yr | -18.4%▼ | -1.3% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹926 Cr +19.0% | ₹778 Cr +12.6% | ₹691 Cr +0.7% | ₹686 Cr +40.8% | ₹487 Cr +44.8% | ₹336 Cr +9.9% | ₹306 Cr +28.1% | ₹239 Cr |
| Other Income | ₹9 Cr +120.0% | ₹4 Cr -46.3% | ₹7 Cr +67.9% | ₹4 Cr +315.9% | ₹1 Cr +674.8% | ₹0.14 Cr +39.2% | ₹0.10 Cr -80.4% | ₹0.51 Cr |
| Total Income | ₹934 Cr +19.5% | ₹782 Cr +12.0% | ₹698 Cr +1.1% | ₹691 Cr +41.4% | ₹488 Cr +45.1% | ₹337 Cr +9.9% | ₹306 Cr +27.8% | ₹240 Cr |
| COGS | ₹498 Cr +17.8% | ₹423 Cr +10.6% | ₹382 Cr -1.5% | ₹389 Cr +41.3% | ₹275 Cr +39.1% | ₹198 Cr +7.3% | ₹184 Cr +30.9% | ₹141 Cr |
| ₹885 Cr +23.3% | ₹718 Cr +11.2% | ₹646 Cr +4.2% | ₹620 Cr +43.6% | ₹431 Cr +47.4% | ₹293 Cr +10.4% | ₹265 Cr +26.1% | ₹210 Cr | |
| Profit Before Tax | ₹50 Cr -0.6% | ₹50 Cr -5.0% | ₹53 Cr -25.9% | ₹71 Cr +24.7% | ₹57 Cr +29.8% | ₹44 Cr +6.6% | ₹41 Cr +40.5% | ₹29 Cr |
| Exceptional Items | ₹0.00 Cr +100.0% | (₹14 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr -100.0% | ₹0.11 Cr +8.8% | ₹0.10 Cr |
| ₹14 Cr -5.5% | ₹15 Cr -10.5% | ₹17 Cr -18.7% | ₹21 Cr +69.3% | ₹12 Cr -3.4% | ₹13 Cr +3.6% | ₹12 Cr +49.7% | ₹8 Cr | |
| Net Profit | ₹36 Cr +2.1% | ₹35 Cr -2.3% | ₹36 Cr -28.7% | ₹50 Cr +12.0% | ₹45 Cr +42.4% | ₹31 Cr +9.3% | ₹29 Cr +36.8% | ₹21 Cr |
| Profit (Owners) | ₹36 Cr +2.1% | ₹35 Cr -2.3% | ₹36 Cr -28.7% | ₹50 Cr +12.0% | ₹45 Cr +42.4% | ₹31 Cr +9.3% | ₹29 Cr +36.8% | ₹21 Cr |
| Other Comprehensive Income | ₹1 Cr ↑ Recovery | (₹0.44 Cr) +26.7% | (₹0.60 Cr) ↓ Decline | ₹0.28 Cr ↑ Recovery | (₹0.28 Cr) ↓ Decline | ₹0.06 Cr ↑ Recovery | (₹0.53 Cr) ↓ Decline | ₹0.10 Cr |
| EPS | ₹13.49 | ₹13.20 | ₹13.51 | ₹20.04 | ₹17.90 | ₹13.43 | ₹12.28 | ₹8.98 |
| Diluted Shares | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Profit Or Loss Of Associates | ₹0.40 Cr +100.0% | ₹0.20 Cr +11.1% | ₹0.18 Cr +80.0% | ₹0.10 Cr -44.4% | ₹0.18 Cr -53.7% | ₹0.39 Cr | ₹0.00 Cr | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Neogen Chemicals Limited has informed the Exchange about Transcript
Neogen Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 21, 2026.
Neogen Chemicals Limited has informed the Exchange about Earnings Conference Call Recording.
Neogen Chemicals Limited has informed the Exchange about Link of Recording
Neogen Chemicals Limited has informed the Exchange about Presentation
Neogen Chemicals Limited has informed the Exchange about Investor Presentation
Neogen Chemicals Limited has informed the Exchange regarding a press release dated July 26, 2026, titled "Neogen Chemicals reports strong financial performance Revenue at INR 250 crore, higher by 34...
(Revised) Statement of deviation or variation in utilisation of funds raised through Preferential Issue for the quarter ended June 30, 2026 and Monitoring Agency Report issued by CRISIL Ratings Limite...
Neogen Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Monitoring Agency Report issued by CRISIL Ratings Limited.
Neogen Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Neogen Chemicals Limited has informed the Exchange about Qualified Institutional Placement and other permissible modes for raising of funds.
Neogen Chemicals Limited has informed the Exchange regarding Change in Auditors of the company.
Neogen Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026 : Approval of financials for the quarter ended June 30, 2026, Statement of Deviation/ variat...
Neogen Chemicals Limited has informed the Exchange that Record date for the purpose of Dividend is 13-Aug-2026.